Mylan Laboratories India Opposition, Glatiramer Acetate Injection , (2234/Delnp/2007 (Eq. Pct/Us2005/032395 And Us60/608,843))
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
MSN Laboratories Private Limited opposition, Ledipasvir, (9313/DELNP/2011)
Countries: India Date: 2016
-
Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)
Countries: India Date: 2016
-
Indian Pharmaceutical Alliance (IPA) opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))
Countries: India Date: 2016
-
Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)
Countries: India Date: 2016
-
Médecins Sans Frontières (MSF) opposition, Pneumococcal Conjugate Vaccine, (8081/DELNP/2007)
Countries: India Date: 2016
-
Panacea Biotech Limited opposition, Pneumococcal Conjugate Vaccine, (10072/DELNP/2012)
Countries: India Date: 2016
-
Panacea Biotech Ltd. opposition, Pneumococcal Conjugate Vaccine, (2533/KOLNP/2008)
Countries: India Date: 2016
-
Dalbir Singh opposition, Daclatasvir , (854/DELNP/2010)
Countries: India Date: 2016
-
Indian Pharmaceutical Alliance opposition, Empagliflozin, (7213/DELNP/2007)
Countries: India Date: 2016
-
Sanjeev Sharma opposition, Dolutegravir, (3865/KOLNP/2007)
Countries: India Date: 2016